Skip to main content
Publications
Martin-Richard M, Gallego R, Pericay C, Garcia Foncillas JG, Queralt B, Casado E, Barriuso J, Iranzo V, Juez I, Visa L, Saigi E, Barnadas A, Garcia-Albeniz X, Maurel J. Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study. Invest New Drugs. 2013 Dec;31(6):1573-9.
Garcia-Albeniz X, Rudolph A, Hutter CM, Lin Y, White E, Brenner H, Casey G, Gallinger S, Hsu L, Hudson TJ, Le Marchand L, Potter J, Slattery M, Zanke B, Newcomb PA, Chan AT, Peters U, Chang-Claude J. Genome wide gene-environment interaction study identifies a CYP24A1-related variant as a modifier of colorectal cancer risk associated with menopausal estrogen plus progesterone therapy. Presented at the 2013 American Society for Human Genetics Annual Meeting; October 24, 2013. Boston, MA.
Garcia-Albeniz X, Nan H, Valeri L, Morikawa T, Kuchiba A, Phipps AI, Hutter CM, Peters U, Newcomb PA, Fuchs CS, Giovannucci EL, Ogino S, Chan AT. Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival. Carcinogenesis. 2013 Feb;34(2):292-8. doi: 10.1093/carcin/bgs335